CoChat
Cited by 187

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

Open access
IJzerman-Korevaar, Margriet, Snijders, Tom J., de Graeff, Alexander, Teunissen, Saskia C. C. M., de Vos, Filip Y. F. · 2018 · Journal of Neuro-Oncology

Abstract

BACKGROUND: Glioma patients suffer from a wide range of symptoms which influence quality of life negatively. The aim of this review is to give an overview of symptoms most prevalent in glioma patients throughout the total disease trajectory, to be used as a basis for the development of a specific glioma Patient Reported Outcome Measure (PROM) for early assessment and monitoring of symptoms in glioma patients. METHODS: A systematic review focused on symptom prevalence in glioma patients in different phases of disease and treatment was performed in MEDLINE, CINAHL and EMBASE according to PRISMA recommendations. We calculated weighted means for prevalence rates per symptom. RESULTS: The search identified 2.074 unique papers, of which 32 were included in this review. In total 25 symptoms were identified. The ten most prevalent symptoms were: seizures (37%), cognitive deficits (36%), drowsiness (35%), dysphagia (30%), headache (27%), confusion (27%), aphasia (24%), motor deficits (21%), fatigue (20%) and dyspnea (20%). CONCLUSIONS: Eight out of ten of the most prevalent symptoms in glioma patients are related to the central nervous system and therefore specific for glioma. Our findings emphasize the importance of tailored symptom care for glioma patients and may aid in the development of specific PROMs for glioma patients in different phases of the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11060-018-03015-9

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 187

Metadata

Authors
IJzerman-Korevaar, M., Snijders, T. J., de Graeff, A., Teunissen, S. C. C. M., & de Vos, F. Y. F.
Venue
Journal of Neuro-Oncology
Published
2018-10-30
Volume
140
Issue
3
Pages
485-496
ISSN
  • 0167-594X (ISSN-L)
  • 1573-7373
OpenAlex
W2899363944
Cited by
187
References
5
FWCI
1.05
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. https://app.cochat.ai/papers/10.1007/s11060-018-03015-9
The paper
IJzerman-Korevaar, M., Snijders, T. J., de Graeff, A., Teunissen, S. C. C. M., & de Vos, F. Y. F. (2018). Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-018-03015-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.